William E. Carson

20.7k total citations · 2 hit papers
313 papers, 14.2k citations indexed

About

William E. Carson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, William E. Carson has authored 313 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Oncology, 137 papers in Immunology and 82 papers in Molecular Biology. Recurrent topics in William E. Carson's work include Immune Cell Function and Interaction (76 papers), Immunotherapy and Immune Responses (38 papers) and Cancer Immunotherapy and Biomarkers (36 papers). William E. Carson is often cited by papers focused on Immune Cell Function and Interaction (76 papers), Immunotherapy and Immune Responses (38 papers) and Cancer Immunotherapy and Biomarkers (36 papers). William E. Carson collaborates with scholars based in United States, China and Canada. William E. Carson's co-authors include Michael A. Caligiuri, Todd A. Fehniger, Barbara L. Andersen, Robin Parihar, Joseph Markowitz, William B. Farrar, Lisa M. Thornton, Megan A. Cooper, Robert Wesolowski and Gregory B. Lesinski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

William E. Carson

307 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

2001 1.1k citations William E. Carson, Michael A. Caligiuri et al. profile →
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

1994 943 citations William E. Carson, Michael A. Caligiuri et al. profile →

Peers

Countries citing papers authored by William E. Carson

Since Specialization

Citations

This map shows the geographic impact of William E. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Carson more than expected).

Fields of papers citing papers by William E. Carson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Carson. The network helps show where William E. Carson may publish in the future.

Co-authorship network of co-authors of William E. Carson

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Carson. A scholar is included among the top collaborators of William E. Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Carson. William E. Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer 2025 ·Cancer Immunology Research ·Emily Schwarz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lianbo Yu, Gregory K. Behbehani, Timothy P. Cripe, William E. Carson	2
2	The Implications of Racialized Economic Segregation and Allostatic Load on Mortality in Patients with Breast Cancer 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), Mohamed I. Elsaid, Jesse J. Plascak, Barbara L. Andersen, William E. Carson, Timothy M. Pawlik, Ruth C. Carlos, Samilia Obeng‐Gyasi	8
3	Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients’ access to novel therapeutics 2023 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Roger Li, Anil V. Parwani, William E. Carson, Kamal S. Pohar, Debasish Sundi	1
4	Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON 2018 ·Cancer Immunology Research ·Zhiwei Hu, Rulong Shen, (unknown), Elizabeth L. McMichael, Lianbo Yu, Bhuvaneswari Ramaswamy, Cheryl A. London, Tian Xu, William E. Carson	33
5	MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions 2017 ·Cancer Immunology Research ·Amanda R. Campbell, Megan Duggan, Lorena P. Suarez‐Kelly, (unknown), (unknown), Elizabeth L. McMichael, Prashant Trikha, Robin Parihar, (unknown), (unknown), Bryant C. Yung, Robert J. Lee, David H. Raulet, Susheela Tridandapani, Veronika Groh, Lianbo Yu, Vedat Yildiz, John C. Byrd, Michael A. Caligiuri, William E. Carson	15
6	A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer 2016 ·Molecular Cancer Therapeutics ·Erin M. Bertino, Elizabeth L. McMichael, Xiaokui Mo, Prashant Trikha, Melanie E. Davis, (unknown), Michael R. Grever, William E. Carson, Gregory A. Otterson	22
7	Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 Years 2016 ·Clinical Cancer Research ·Barbara L. Andersen, Neha Goyal, (unknown), (unknown), William E. Carson	36
8	IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells 2016 ·Clinical Cancer Research ·Elizabeth L. McMichael, Alena Cristina Jaime‐Ramirez, Kristan Guenterberg, (unknown), (unknown), Amanda R. Campbell, Zhiwei Hu, (unknown), Sri Vidya Kondadasula, Xiaokui Mo, Susheela Tridandapani, Mark Bloomston, E. Christopher Ellison, Terence M. Williams, Tanios Bekaii‐Saab, William E. Carson	55
9	RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment 2015 ·Cancer Research ·Mohd W. Nasser, Nissar Ahmad Wani, Dinesh K. Ahirwar, Catherine A. Powell, Janani Ravi, Mohamad Elbaz, Helong Zhao, Laura Padilla, Xiaoli Zhang, Konstantin Shilo, Michael C. Ostrowski, Charles L. Shapiro, William E. Carson, Ramesh K. Ganju	124
10	Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer 2014 ·Journal of Carcinogenesis & Mutagenesis ·Robert Wesolowski, William E. Carson	7
11	Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta 2013 ·Arthritis Research & Therapy ·Yong Seok Choi, Jin Kyun Park, Eun Ha Kang, Young‐Kyun Lee, Tae Kyun Kim, Jin-Haeng Chung, Jason M. Zimmerer, William E. Carson, Yeong Wook Song, Yun Jong Lee	23
12	Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice 2011 ·Cancer Research ·Bethany L. Mundy-Bosse, Gregory B. Lesinski, Alena Cristina Jaime‐Ramirez, Kristen Benninger, Mahmood Khan, Periannan Kuppusamy, Kristan Guenterberg, Sri Vidya Kondadasula, Abhik Ray Chaudhury, Krista M. D. La Perle, (unknown), Gregory Young, Denis C. Guttridge, William E. Carson	149
13	BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma 2011 ·Journal of Clinical Oncology ·Kevin B. Kim, Jeffrey A. Sosman, John P. Fruehauf, Gerald P. Linette, Svetomir N. Markovic, David F. McDermott, Jeffrey S. Weber, Hoa Nguyen, Peter Cheverton, Daniel S. Chen, Amy Peterson, William E. Carson, Steven O’Day	148
14	IFN-α and Bortezomib Overcome Bcl-2 and Mcl-1 Overexpression in Melanoma Cells by Stimulating the Extrinsic Pathway of Apoptosis 2008 ·Cancer Research ·Gregory B. Lesinski, (unknown), Kristan Guenterberg, (unknown), Michael R. Go, Nisha Shah, (unknown), (unknown), Erinn M. Hade, Gregory Young, Abhik Ray Chaudhury, Katherine J. Ladner, Denis C. Guttridge, Page Bouchard, William E. Carson	44
15	Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α 2008 ·Clinical Cancer Research ·Jason M. Zimmerer, Gregory B. Lesinski, Amy S. Ruppert, Michael D. Radmacher, (unknown), Kari Kendra, Michael J. Walker, William E. Carson	27
16	Melanoma Cells Exhibit Variable Signal Transducer and Activator of Transcription 1 Phosphorylation and a Reduced Response to IFN-α Compared with Immune Effector Cells 2007 ·Clinical Cancer Research ·Gregory B. Lesinski, John C. Trefry, (unknown), Sri Vidya Kondadasula, (unknown), Jason M. Zimmerer, Abhik Ray Chaudhury, Lianbo Yu, Xiaoli Zhang, (unknown), Michael J. Walker, William E. Carson	30
17	The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse 2003 ·Journal of Clinical Investigation ·Gregory B. Lesinski, Mirela Anghelina, Jason M. Zimmerer, (unknown), Brian D. Badgwell, Robin Parihar, Yan Hu, Brian Becknell, Gerard Abood, Abhik Ray Chaudhury, Cynthia M. Magro, Joan E. Durbin, William E. Carson	97
18	IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells 2002 ·Journal of Clinical Investigation ·Robin Parihar, Julie Dierksheide, Yan Hu, William E. Carson	16
19	IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells 2002 ·Journal of Clinical Investigation ·Robin Parihar, Julie Dierksheide, (unknown), William E. Carson	137
20	Social Change and Rational Choice: A Contemporary Interpretation of the Amish 1998 ·OhioLink ETD Center (Ohio Library and Information Network) ·William E. Carson	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact